Medicamen Organics IPO Review

 
Medicamen Organics IPO Review

IPO Open Date: June 21, 2024

IPO Close Date: June 25, 2024

IPO Price: ₹32 to ₹34 per share

Lot Size: 4000 Shares

Listing: June 28, 2024

Medicamen Organics is scheduled to hit the market on June 21, 2024 and close on June 25, 2024. Medicamen Organics plans to raise around ₹10.54 Cr through an IPO with a sale of up to 3,100,000 equity shares of ₹10 each. The Retail offered 35%, QIB Shares Offered 50%, HNI Shares Offered 15%.

Medicamen Organics Limited, established in 1995, specializes in developing, manufacturing, and distributing a wide range of pharmaceutical dosages, including generic tablets, capsules, oral liquids, ointments, and syrups. The company caters to both governmental bodies, such as State and Central Governments, and private entities by serving as a contract manufacturer. With a product portfolio of 84 items, their offerings span various categories like antibacterial, antidiabetic, antifungal, and antimalarial drugs, among others. These products are not only available across India but also reach markets in African, CIS, and South East Asian countries through third-party distributors.

The company operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering a substantial area of 21,536 sq. ft. Medicamen Organics Limited has established partnerships with 38 domestic collaborators and 12 merchant exporters for contract manufacturing purposes. As of September 30, 2023, the company had a workforce of 116 individuals dedicated to ensuring the production and distribution of high-quality pharmaceutical products to meet the diverse healthcare needs of their clients across different regions.

Medicamen Organics



Medicamen Organics IPO Details

Medicamen Organics IPO opens on June 21, 2024, and closes on June 25, 2024. The Listing date for Medicamen Organics IPO is on June 28, 2024. The price band for IPO is ₹32 to ₹34 per share and lot size of 4000 Shares.

IPO DateJune 21, 2024 to June 25, 2024
Listing DateJune 28, 2024
Price₹32 to ₹34 per share
Lot Size4000 Shares
Issue Size₹10.54 Cr
Face Value₹10 per share

Medicamen Organics IPO Tentative Timetable

Medicamen Organics opening date is June 21, 2024 and close date is June 25, 2024. The IPO allotment date is June 26, 2024. The refund initiation of IPO is on June 27, 2024. The credit of shares in demat account is on June 27, 2024. The listing date is on June 28, 2024.

EventDate
IPO OpeningJune 21, 2024
IPO ClosingJune 25, 2024
IPO Allotment DateJune 26, 2024
Refund InitiationJune 27, 2024
Shares Credit to DematJune 27, 2024
Lisiting DateJune 28, 2024

Medicamen Organics IPO Lot Size

Lot Size of this IPO is 4000 shares. A retail-individual investor can apply for up to 1 lots (4000 shares or ₹136,000).

CategoryLotsSharesAmount
Retail(Minimum)14000₹136,000
Retail(Maximum)14000₹136,000
S-HNI (Minimum)28000₹272,000

Medicamen Organics IPO Promoter Holding

Pre Issue Share Holding81.21%
Post Issue Share Holding

Medicamen Organics IPO Review

Medicamen Organics Limited has shown strong financial growth in recent years. The company's revenue increased by 8.38% from Rs. 2,118.67 lakhs in FY22 to Rs. 2,296.24 lakhs in FY23. More impressively, the profit after tax (PAT) surged by 937.7% from Rs. 9.23 lakhs in FY22 to Rs. 95.78 lakhs in FY23. For the period ending September 30, 2023, the company reported revenue of Rs. 1,132.60 lakhs and a PAT of Rs. 129.11 lakhs. The company's assets have also grown, standing at Rs. 3,450.88 lakhs as of September 30, 2023, with a net worth of Rs. 1,180.83 lakhs. Medicamen Organics' financial performance indicates robust growth and profitability, supported by a steady increase in revenue and substantial improvements in profit margins.

The upcoming IPO for Medicamen Organics aims to raise Rs. 39.78 crore. The company plans to use the net proceeds for product registration in international markets, plant updation, increasing production capacity, funding working capital requirements, and general corporate purposes. The IPO is priced with a pre-IPO EPS of 1.11 and a post-IPO EPS of 2.21, translating to a P/E ratio of 30.53x pre-IPO and 15.41x post-IPO. These valuations suggest a relatively reasonable pricing strategy, especially considering the company’s significant growth in profitability and stable financials.

Medicamen Organics Limited has demonstrated strong financial resilience and growth, especially evident in its impressive profit surge from FY22 to FY23. The company's strategic focus on expanding its product registration in international markets and enhancing its production capacity bodes well for future growth. While the pharmaceutical industry remains competitive, Medicamen Organics' diverse product portfolio, WHO-GMP-approved manufacturing facilities, and established market presence both domestically and internationally provide a solid foundation for continued success. The IPO appears reasonably priced given the company's financial performance and growth prospects. Investors with a medium to long-term investment horizon might find Medicamen Organics a compelling opportunity, considering its robust growth trajectory and strategic expansion plans. The focus on funding key growth areas through the IPO proceeds further enhances the company's potential for sustained growth and profitability.

Medicamen Organics IPO Subscription Status (Bidding Details)

Table not found

Medicamen Organics IPO Broker Recommendations

  • Capital Market: To be updated soon
  • Anand Rathi: To be updated soon
  • SMC Global: To be updated soon
  • Arihant Capital: To be updated soon

Medicamen Organics IPO FAQs

What is Medicamen Organics IPO?

Medicamen Organics is issuing 3,100,000 equity shares with a face value of ₹10 each, totaling up to ₹10.54 Cr. The shares are being offered at a price of ₹32 to ₹34 each, with a minimum order quantity of 4000 shares.

Kfin Technologies Limited is the registrar for the IPO, and the shares are planned to be listed on the BSE and NSE.

When Medicamen Organics IPO will open?

Medicamen Organics will open on June 21, 2024 for QIB, NII, and Retail Investors.

When Medicamen Organics IPO will end?

Medicamen Organics will end on June 24, 2024.

What is Medicamen Organics IPO Size?

Medicamen Organics IPO size is 10.54 Cr.

What is Medicamen Organics IPO Price Band?

Medicamen Organics price band is ₹32 to ₹34 per share.

What is the Medicamen Organics IPO Allotment Date?

Medicamen Organics allotment date is June 26, 2024.

What is the Medicamen Organics IPO Listing Date?

Medicamen Organics listing date is June 28, 2024. The IPO is to be listed on BSE and NSE.

How to Medicamen Organics IPO through Zerodha?

To apply for the IPO “Medicamen Organics” on Zerodha, log in to the Zerodha website or app, go to the Portfolio section, and click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Zerodha.

How to Apply Medicamen Organics IPO through Upstox?

To apply for the IPO “Medicamen Organics” on Upstox, log in to the Upstox website or app, click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Upstox.

How to check Medicamen Organics IPO Allotment Status?

For Medicamen Organics IPO Allotment status check you can visit this link, select the desired IPO and enter your PAN to check the allotment status.

What is Medicamen Organics IPO GMP?

You can check out here: Medicamen Organics IPO GMP

Sharing Is Caring:
Avatar of Ishika Agarwal
About Ishika Agarwal

Ishika Agarwal is a seasoned financial writer with a strong background in the stock market and investment sector. Ishika has a passion for analyzing and interpreting complex financial data to provide valuable insights to her readers.

Leave a Comment